Stewart Italia srl

About Stewart Italia srl

STEWART ITALIA was founded in Milan in 2004 with the aim of representing foreign partners in Italy. The company's mission is to identify possible improvements to commonly used products to allow for safer, simpler, or more useful use. To achieve this, it has implemented a network of highly cultured and prepared ISFs (Medical Information Representatives) who, with the company's intent, must recreate the doctor-representative relationship, making it more effective, more professional, and above all, restoring the ISF's role as a trainer for the doctor. It was the first in Italy to begin the experimentation and commercialization of the 3% hypertonic saline solution, establishing the RINOREX brand. In 2012, in collaboration with partner Medreich Pharma, it registered an evolution of Amoxicillin + Clavulanic Acid in suspension for pediatric use. STEWART ITALIA entrusts its development to a strong innovation in marketing and communication methods. Thanks to innovative work methods, it has built greater efficiency in scientific information by organizing training courses, meetings, and updates, becoming an important reference for family doctors, hospital doctors, and specialists.